• Aucun résultat trouvé

Cord blood transplantation

Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia : a survey on behalf of Eurocord and CLWP of EBMT

Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia : a survey on behalf of Eurocord and CLWP of EBMT

... leukemia, transplantation from an HLA-matched or one HLA allele- mismatched unrelated donor is associated with 5–10 and 10–15% lower survival rates, respectively, when compared with transplantation from an ...

7

Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study

Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study

... donor transplantation may be considered, but results from previous studies are not ...unrelated cord blood (CB) transplantation (CBT) efficacy and safety in refractory SAA patients (Aplastic ...

5

Natural killer cell licensing after double cord blood transplantation is driven by the self-HLA class I molecules from the dominant cord blood

Natural killer cell licensing after double cord blood transplantation is driven by the self-HLA class I molecules from the dominant cord blood

... of cord blood transplan- tation: HLA matching, cell dose and other graft- and transplantation- related ...double-unit cord blood transplantation and is influenced by bank ...

5

Cord blood transplantation in a child with Pearson's disease.

Cord blood transplantation in a child with Pearson's disease.

... and blood products requirements increased; dysplasic features of red cells and platelet precursors were ...unrelated cord blood transplantation (CBT) was performed at the age of nearly 3 ...

1

Effect of HLA-matching recipients to donor non-inherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy

Effect of HLA-matching recipients to donor non-inherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy

... umbilical cord blood transplantation for hematologic malignancy Vanderson Rocha, MD, PhD Stephen Spellman, MS Mei-Jie Zhang, PhD Annalisa Ruggeri, MD Duncan Purtill, MD Colleen Brady, BS Lee Ann ...

26

Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen

Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen

... Umbilical cord blood transplant recipients are exposed to an increased risk of graft failure, a complication leading to a higher rate of transplant-related ...umbilical cord blood ...

8

Reconstitution of adaptive immunity after umbilical cord blood transplantation and clinical implication regarding risk of infections

Reconstitution of adaptive immunity after umbilical cord blood transplantation and clinical implication regarding risk of infections

... after transplantation undergo intense expansion, until they reach a number that is in the range of the mature pool in normal ...peripheral blood during the first months after ...

13

Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood

Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood

... unrelated cord blood transplantation for patients with lymphoid malignan- ...umbilical cord blood (n=104) or mobilized peripheral blood stem cells (n=541) after a ...

9

Umbilical cord blood banking

Umbilical cord blood banking

... umbilical cord blood transplant is very low in the general population, so that it is currently highly unlikely for a family with no history of blood disease or metabolic disorder to ever need banked ...

7

Umbilical cord blood versus unrelated donor transplantation in adults with primary refractory or relapsed acute myeloid leukemia: a report from Eurocord, the Acute Leukemia Working Party and the Cord Blood Committee of the Cellular Therapy and Immunobiolo

Umbilical cord blood versus unrelated donor transplantation in adults with primary refractory or relapsed acute myeloid leukemia: a report from Eurocord, the Acute Leukemia Working Party and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the EBMT

... umbilical cord blood transplantation (CBT) in acute myeloid leukemia (AML) patients with active disease at allogeneic hematopoietic cell transplantation (allo-HCT) remains poorly ...compared ...

8

Umbilical cord blood versus unrelated donor transplantation in adults with primary refractory or relapsed acute myeloid leukemia: a report from Eurocord, the Acute Leukemia Working Party and the Cord Blood Committee of the Cellular Therapy and Immunobiolo

Umbilical cord blood versus unrelated donor transplantation in adults with primary refractory or relapsed acute myeloid leukemia: a report from Eurocord, the Acute Leukemia Working Party and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the EBMT.

... umbilical cord blood transplantation (CBT) in acute myeloid leukemia (AML) patients with active disease at allogeneic hematopoietic cell transplantation (allo-HCT) remains poorly ...compared ...

7

Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation.

Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation.

... marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of ...

21

T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation.

T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation.

... Fifty consecutive patients ineligible for a myeloablative allogeneic HSCT were initially included. Fifteen patients were excluded from the analysis of immune reconstitution because of early death (n ⫽10), early graft ...

9

Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients

Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients

... 2. Results 2.1. Peripheral and umbilical cord blood NK expansion NK cells were expanded using two different protocols. UCB NK cells, due to their need for both KIR and KAR signals to reach a mature ...

13

Toxic trace elements in maternal and cord blood and social determinants in a Bolivian mining city

Toxic trace elements in maternal and cord blood and social determinants in a Bolivian mining city

... Whole Blood, Level 1 (lowest available con- centrations) and Level 2 (elevated concentrations)- two digestion blanks and two sub- samples of the pooled blood control sample from this ...

19

Fatty acid profile in cord blood of neonates born to optimally controlled gestational diabetes mellitus

Fatty acid profile in cord blood of neonates born to optimally controlled gestational diabetes mellitus

... 2.5. Blood sample analyses Maternal A 1C, (normal range ...the cord plasma were extracted and separated into PL, TG, CE and NEFA by thin layer ...[18]. Cord plasma glucose, total cholesterol, total ...

14

Accelerated senescence of cord blood endothelial progenitor cells in premature neonates is driven by SIRT1 decreased expression

Accelerated senescence of cord blood endothelial progenitor cells in premature neonates is driven by SIRT1 decreased expression

... immuno fluorescent staining of vascular markers evidenced the im- paired capacity of PT-ECFC to form blood vessels compared with CT-ECFCs (Figure 7Aiii-iv vs Av-vi, Ba-c vs Bd-f, C). In implants containing ...

12

CORD DONOR Safety

CORD DONOR Safety

... Umbilical Cord Clamping After Birth ,The American College of Obstetricians and Gynecologists, December 2012 • Rabe et ...delayed cord clamping to increase placental transfusion in preterm neonates, The ...

40

Show all 1365 documents...

Sujets connexes